Ann: Increased Sales Lead to Record Monthly Product Shipments, page-148

First 148 Last

Share
Profile

Follow
mandp

1,625 Posts.

68

27/06/17

12:29

Post #: 25512990
Share

Originally posted by maybe2014 ↑

This is a very revealing post. Both Pintoo and Parsifal have been long time, all too often overly exuberant and very personal supporters of AJX, particularly of NC.
Reading this and other recent posts, there has clearly been a major change in the both the business and personal relationships.

"Moreover, while Nick has said he has a lot of experience on US listings and I know I have supported him in terms of his impact on the business I can tell you that in conversations I had with him his knowledge of ADRs was bizarrely lacking and less than I could understand from reading everything I could lay my hands on. That matches with the strange fanfare on the NASDAQ international designation which is nothing more than a marketing platform launched by NASDAQ. We couldn't list while the Susta case was ongoing - well we could have but it would have made things awfully public - but that was settled in January."

Just read that again; "I can tell you that in conversations I had with him his knowledge of ADRs was bizarrely lacking..."
WTF???

This is the major reason I questioned the personal relationship between Pinto and Parsifal and NC from the beginning. Many posters were damning of me and thought that the opportunity of receiving information from "behind the scenes" was invaluable.
From my view point, when relationships go bad, they can be extremely damaging and this looks like it could be nasty.

Expand

Maybe....looking into it too much?.....lol

AJX Price at posting: 55.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

IRE

Iress runs 'hot' for Wealth Within's stock tips

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 60 more messages in this thread...

First 148 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.000(0.00%)		Mkt cap ! $17.31M

Open	High	Low	Value	Volume
1.1¢	1.3¢	1.1¢	$8.95K	812.8K

Buyers (Bids)

No.	Vol.	Price($)
1	109618	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	58333	1

View Market Depth

No.	Vol.	Price($)
1	109618	0.011
2	1059013	0.010
5	2072715	0.009
4	4186222	0.008
3	349012	0.007

Price($)	Vol.	No.
0.013	58333	1
0.015	431158	2
0.017	321118	2
0.018	115942	2
0.019	12500	1

Last trade - 15.34pm 01/10/2024 (20 minute delay)

AJX (ASX) Chart

Ann: Increased Sales Lead to Record Monthly Product Shipments, page-148

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Increased Sales Lead to Record Monthly Product Shipments, page-148

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Iress runs 'hot' for Wealth Within's stock tips

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News